Group leader

Harry Heimberg

Harry Heimberg received a PhD in Molecular Biology from the Vrije Universiteit Brussel (VUB) in Brussels. He went for a postdoc at the department for Cell Biology and Physiology at Washington University Medical School (St-Louis) and returned to Brussels in 1996 to join the Diabetes Research Center-VUB where he studies mechanisms that drive beta cell neogenesis in order to contribute to a cell therapy in diabetes. Harry Heimberg is professor Biochemistry, Microbiology and Molecular Biology at VUB. Since 2009 he coordinates an institutional collaboration between VUB and the Hubrecht Institute to investigate the power of stem/progenitor cells in pancreas for beta cell therapy. Harry Heimberg obtained postdoctoral fellowships from the Fund for Scientific Research, Flanders and the Juvenile Diabetes Research Foundation (1996), a Career Development Award from JDRF (2000), the Dupont Award from the Royal Academy for Medicine in Belgium (2003) and the Pfizer Award for Innovating Research (2005).

About the research
Publication list